Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bourin

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Journal De Pharmacologie|October 1, 1986
[Implantation of a permanent flexible permanent cannula duodenal in the rabbit, application to the study of drug resorption]M Bourin, M F Kergueris, A Ortega
Psychopharmacology|May 5, 1998
Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming testM Bourin, J P Redrobe, G B Baker
Pharmacology, Biochemistry, and Behavior|January 4, 1998
Influence of prior experience on mice behavior using the four-plate testM Hascoet, M Bourin, A Couetoux du Tertre
Arzneimittel-Forschung|January 1, 1983
The value of the reserpine test in psychopharmacologyM Bourin, M Poncelet, R Chermat, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
The mouse light-dark paradigm: a reviewM Hascoët, M Bourin, B A Nic Dhonnchadha
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1985
Theoretical study of haemoperfusion: drugs obeying a one-compartment pharmacokinetics modelJ Guenzet, M Bourin, D Laurent, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placeboM Bourin, T Bougerol, B Guitton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 13, 2000
Effect of CCK-4 on a 35% carbon dioxide challenge in healthy volunteersH Pols, E Griez, M Bourin, et al.
Neuroscience and Biobehavioral Reviews|March 12, 1999
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humansK M Hegadoren, G B Baker, M Bourin
Fundamental & Clinical Pharmacology|January 1, 1996
Two faces of cholecystokinin: anxiety and schizophreniaM Bourin, M Malinge, E Vasar, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Journal De Pharmacologie|October 1, 1986
[Implantation of a permanent flexible permanent cannula duodenal in the rabbit, application to the study of drug resorption]M Bourin, M F Kergueris, A Ortega
Psychopharmacology|May 5, 1998
Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming testM Bourin, J P Redrobe, G B Baker
Pharmacology, Biochemistry, and Behavior|January 4, 1998
Influence of prior experience on mice behavior using the four-plate testM Hascoet, M Bourin, A Couetoux du Tertre
Arzneimittel-Forschung|January 1, 1983
The value of the reserpine test in psychopharmacologyM Bourin, M Poncelet, R Chermat, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
The mouse light-dark paradigm: a reviewM Hascoët, M Bourin, B A Nic Dhonnchadha
Methods and Findings in Experimental and Clinical Pharmacology|May 1, 1985
Theoretical study of haemoperfusion: drugs obeying a one-compartment pharmacokinetics modelJ Guenzet, M Bourin, D Laurent, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placeboM Bourin, T Bougerol, B Guitton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 13, 2000
Effect of CCK-4 on a 35% carbon dioxide challenge in healthy volunteersH Pols, E Griez, M Bourin, et al.
Neuroscience and Biobehavioral Reviews|March 12, 1999
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humansK M Hegadoren, G B Baker, M Bourin
Fundamental & Clinical Pharmacology|January 1, 1996
Two faces of cholecystokinin: anxiety and schizophreniaM Bourin, M Malinge, E Vasar, et al.
Pageof 21